mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0003 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
0.0006 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
SNX-2112 |
GDSC1000 |
pan-cancer |
AAC |
-0.096 |
0.002 |
mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.002 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |